"RWJBarnabas Health Cancer Care is how we link multiple hospitals to hundreds of local cancer specialists. It’s where precision medicine, genomics and clinical trials come together every day to help our patients and put a cure within reach through a partnership with Rutgers Cancer Institute of New Jersey. Exemplary care and service paired with access to advanced technologies and the latest protocols available is how we’re bringing high-quality cancer care close to home. Visit our website to learn more."

During the past decade, Cancer Institute of New Jersey At Hamilton conducted 27 clinical trials. In the 10-year time frame, 27 clinical trials started and 38 clinical trials were completed, i.e. on average, 140.7% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 16 clinical trials were completed. i.e. 177.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cancer Institute of New Jersey At Hamilton" #1 sponsor was "National Cancer Institute (NCI)" with 29 trials, followed by "ECOG-ACRIN Cancer Research Group" with 10 trials sponsored, "Rutgers, The State University of New Jersey" with 10 trials sponsored, "University of Medicine and Dentistry of New Jersey" with 10 trials sponsored and "Alliance for Clinical Trials in Oncology" with 10 trials sponsored. Other sponsors include 21 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cancer Institute of New Jersey At Hamilton" #1 collaborator was "National Cancer Institute (NCI)" with 59 trials as a collaborator, "Cancer and Leukemia Group B" with 8 trials as a collaborator, "SWOG Cancer Research Network" with 8 trials as a collaborator, "NCIC Clinical Trials Group" with 7 trials as a collaborator and "NRG Oncology" with 7 trials as a collaborator. Other collaborators include 38 different institutions and companies that were collaborators in the rest 28 trials.

According to Clinical.Site data, the most researched conditions in "Cancer Institute of New Jersey At Hamilton" are "Breast Cancer" (15 trials), "Lung Cancer" (9 trials), "Invasive Breast Carcinoma" (7 trials), "Prostate Cancer" (5 trials) and "Stage IIIA Breast Cancer" (5 trials). Many other conditions were trialed in "Cancer Institute of New Jersey At Hamilton" in a lesser frequency.

Most popular intervention types in "Cancer Institute of New Jersey At Hamilton" are "Drug" (76 trials), "Other" (41 trials), "Biological" (28 trials), "Procedure" (17 trials) and "Radiation" (15 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (19 trials), "Laboratory Biomarker Analysis" (18 trials), "Paclitaxel" (11 trials), "Questionnaire Administration" (10 trials) and "Bevacizumab" (9 trials). Other intervention names were less common.

The vast majority of trials in "Cancer Institute of New Jersey At Hamilton" are 59 trials for "All" genders, 25 trials for "Female" genders and 9 trials for "Male" genders.

Currently, there are NaN active trials in "Cancer Institute of New Jersey At Hamilton". undefined are not yet recruiting, 13 are recruiting, 29 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 32 completed trials in Cancer Institute of New Jersey At Hamilton, 1 suspended trials, and 16 terminated clinical trials to date.

Out of the total trials that were conducted in Cancer Institute of New Jersey At Hamilton, 3 "Phase 1" clinical trials were conducted, 36 "Phase 2" clinical trials and 56 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".